NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026)
NovoCure (NVCR) posted Amortizatization of Intangibles of -$2.6 million for Q2 2026, up 0.92% sequentially from -$2.6 million in Q1 2026, and up 59.86% YoY from -$1.6 million in Q2 2025.
NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
NovoCure has reported Amortizatization of Intangibles for 13 years, with the latest figure at -$2.6 million in Q2 2026.
- Quarterly Amortizatization of Intangibles rose 59.86% year-over-year to -$2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$15.4 million (up 42.1% YoY) and the FY2025 annual result came in at -$23.3 million, up 9.29% from the prior year.
- Amortizatization of Intangibles rose to -$2.6 million in Q2 2026 per NVCR's latest filing, from -$2.6 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $827000.0 in Q2 2022 and troughed at -$7.3 million in Q4 2023.
- A 5-year average of -$4.4 million and a median of -$5.2 million in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles plunged 2984.05% in 2023, then surged 60.67% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at -$3.3 million in 2022, then slumped by 121.47% to -$7.3 million in 2023, then climbed by 8.12% to -$6.7 million in 2024, then soared by 43.85% to -$3.7 million in 2025, then soared by 30.78% to -$2.6 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$2.6 million, -$2.6 million, and -$3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.59 Mn |
| Jun 30, 2026 | -2.59 Mn |
| Mar 31, 2026 | -2.62 Mn |
| Mar 31, 2026 | -2.62 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -6.40 Mn |
| Sep 30, 2025 | -6.40 Mn |
| Jun 30, 2025 | -6.46 Mn |
| Jun 30, 2025 | -6.46 Mn |
| Mar 31, 2025 | -6.65 Mn |
| Mar 31, 2025 | -6.65 Mn |
| Dec 31, 2024 | -6.67 Mn |
| Dec 31, 2024 | -6.67 Mn |
| Sep 30, 2024 | -6.74 Mn |
| Sep 30, 2024 | -6.74 Mn |
| Jun 30, 2024 | -6.85 Mn |
| Jun 30, 2024 | -6.85 Mn |
| Mar 31, 2024 | -5.38 Mn |
| Mar 31, 2024 | -5.38 Mn |